Dissecting the role of medial versus lateral orbitofrontal circuit activity in perseverative behavior

剖析内侧与外侧眶额回路活动在持续行为中的作用

基本信息

  • 批准号:
    10665272
  • 负责人:
  • 金额:
    $ 18.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT: Perseverative behaviors are prominent, disabling, and often treatment- resistant symptoms of several neuropsychiatric disorders including Obsessive Compulsive Disorder (OCD). Perseverative behavior refers to the repetition or continuation of a response that no longer results in a reward or expected outcome. Human neuroimaging data has associated abnormal activity within orbitofronto-striatal circuits with perseverative behavior in OCD patients. While early human neuroimaging studies identified overactivation of the entire orbitofrontal cortex (OFC), more recent studies have linked overactivation of the lateral OFC (lOFC) and hypoactivity of the medial OFC (mOFC) with OCD symptoms. Furthermore, preclinical work in rodents suggests that activating mOFC-striatal projection neurons drives perseverative behavior, while activating lOFC-striatal projection neurons suppresses perseverative behavior. Yet, a substantial gap in knowledge remains regarding the mechanisms underlying the differential regulation of perseverative behavior by the mOFC versus lOFC. This project will use chemogenetic and fiber photometry technologies in freely moving mice to determine how neuronal activity within the mOFC versus lOFC regulate perseverative behaviors. We will induce perseverative behavior in mice using acute challenge with a serotonin 1B receptor (5-HT1BR) agonist. Pharmacological challenge with agonists for the 5-HT1BR, previously termed 5-HT1Dβ in humans, exacerbates symptoms in OCD patients. Similarly, we found that treating mice acutely with a 5-HT1BR agonist induces perseverative behaviors including a highly repetitive form of hyperlocomotion termed “route stereotypy”, and perseverative responding in a delayed alternation task. These 5-HT1BR agonist-mediated effects can be prevented by the only effective monotherapy for OCD, 4 weeks of chronic treatment with SRIs. Thus, acute 5- HT1BR agonist treatment induces perseverative behaviors in mice with relevance to OCD. We will combine fiber photometry and chemogenetics with our well-validated behavioral methods to identify the mechanisms underlying the differential control over perseverative behavior by the mOFC versus lOFC. Previous work reported that optogenetic stimulation of mOFC-ventromedial striatal projections induces perseverative grooming in mice, while other work showed that optogenetic stimulation of lOFC-centromedial striatal projections suppresses perseverative grooming. Here, we will assess the effects of chemogenetic inhibition of neuronal projections from the mOFC versus lOFC to a large centromedial striatal region on 5-HT1BR agonist-induced perseverative behavior. We will also determine whether perseverative behavior is associated with differential changes in serotonin release into the mOFC versus lOFC using GRAB5-HT, and/or differential changes in the activity of GABAergic interneurons or orbitostriatal projection neurons within the mOFC versus lOFC. Since dysfunction within orbitofrontal-striatal circuits and the serotonergic system is also implicated in anorexia nervosa, addictive disorders, and autism spectrum disorders, our findings will be broadly applicable to a number of conditions.
项目总结/摘要:持续性行为是突出的,致残的,通常是治疗- 包括强迫症(OCD)在内的几种神经精神障碍的顽固症状。 持续行为指的是重复或持续的反应,不再导致奖励或奖励。 预期的结果。人类神经影像学数据与眶额-纹状体内异常活动相关 强迫症患者的持续行为。虽然早期的人类神经成像研究发现 整个眶额皮质(OFC)的过度激活,最近的研究表明, 外侧OFC(lOFC)和内侧OFC活动减退(mOFC)伴强迫症症状。此外,临床前 在啮齿动物中的研究表明,激活mOFC-纹状体投射神经元驱动持续行为,而 激活IOFC-纹状体投射神经元抑制持续行为。然而, 关于持续行为的差异调节机制的知识仍然存在 mOFC与IOFC的对比。该项目将在自由移动中使用化学遗传学和纤维光度测定技术 小鼠以确定mOFC与IOFC内的神经元活动如何调节持续行为。我们将 用5-羟色胺1B受体(5-HT 1BR)激动剂急性激发诱导小鼠持续行为。 5-HT 1BR(以前在人体中称为5-HT 1D β)激动剂的药理学挑战加剧 强迫症患者的症状同样,我们发现用5-HT 1BR激动剂急性治疗小鼠, 持续性行为,包括称为“路线刻板”的高度重复形式的过度运动,以及 延迟交替任务中的持续反应。这些5-HT 1BR激动剂介导的作用可以是 通过对强迫症唯一有效的单一疗法,即4周的SRI慢性治疗来预防。因此,急性5- HT 1BR激动剂治疗诱导小鼠与强迫症相关的持续行为。我们将联合收割机纤维 光度学和化学遗传学与我们行之有效的行为方法,以确定机制 这是mOFC与IOFC对持续行为的差异控制的基础。以往报告的工作 mOFC-腹内侧纹状体投射的光遗传学刺激诱导小鼠的持续梳理, 而其他研究表明,光遗传学刺激IOFC-中央纹状体投射抑制 坚持不懈的梳理在这里,我们将评估化学发生抑制神经元投射的影响, 在5-HT 1BR激动剂诱导的持续性高血压中,mOFC与IOFC在纹状体中央内侧区的分布差异不显著。 行为我们还将确定持续行为是否与不同的变化有关, 使用GRAB 5-HT,5-羟色胺释放到mOFC中与IOFC中,和/或 mOFC与IOFC内的GABA能中间神经元或眶纹状体投射神经元。由于功能障碍 在眶额-纹状体回路内,多巴胺能系统也与神经性厌食症、成瘾性 和自闭症谱系障碍,我们的发现将广泛适用于许多条件。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHANIE C DULAWA其他文献

STEPHANIE C DULAWA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHANIE C DULAWA', 18)}}的其他基金

Novel mechanisms mediating the rapid antidepressant actions of glyoxylase 1 inhibitors
介导乙二醛酶 1 抑制剂快速抗抑郁作用的新机制
  • 批准号:
    10557209
  • 财政年份:
    2022
  • 资助金额:
    $ 18.05万
  • 项目类别:
Novel mechanisms mediating the rapid antidepressant actions of glyoxylase 1 inhibitors
介导乙二醛酶 1 抑制剂快速抗抑郁作用的新机制
  • 批准号:
    10351962
  • 财政年份:
    2022
  • 资助金额:
    $ 18.05万
  • 项目类别:
Translating OCD GWAS findings into mice: identifying epistatic modifiers of BTBD3
将 OCD GWAS 研究结果转化为小鼠:识别 BTBD3 的上位修饰因子
  • 批准号:
    8898917
  • 财政年份:
    2014
  • 资助金额:
    $ 18.05万
  • 项目类别:
Translating OCD GWAS findings into mice: identifying epistatic modifiers of BTBD3
将 OCD GWAS 研究结果转化为小鼠:识别 BTBD3 的上位修饰因子
  • 批准号:
    8773096
  • 财政年份:
    2014
  • 资助金额:
    $ 18.05万
  • 项目类别:
Mechanisms underlying fast-onset antidepressant effects of 5-HT2C antagonists - R
5-HT2C 拮抗剂快速起效抗抑郁作用的机制 - R
  • 批准号:
    8699844
  • 财政年份:
    2013
  • 资助金额:
    $ 18.05万
  • 项目类别:
Mechanisms underlying fast-onset antidepressant effects of 5-HT2C antagonists - R
5-HT2C 拮抗剂快速起效抗抑郁作用的机制 - R
  • 批准号:
    8579251
  • 财政年份:
    2013
  • 资助金额:
    $ 18.05万
  • 项目类别:
Mechanisms for 5-HTT control of PPI and perseverative behavior using mouse models
使用小鼠模型研究 5-HTT 控制 PPI 和持续行为的机制
  • 批准号:
    8012515
  • 财政年份:
    2010
  • 资助金额:
    $ 18.05万
  • 项目类别:
Mechanisms for 5-HTT control of PPI and perseverative behavior using mouse models
使用小鼠模型研究 5-HTT 控制 PPI 和持续行为的机制
  • 批准号:
    8038444
  • 财政年份:
    2007
  • 资助金额:
    $ 18.05万
  • 项目类别:
Mechanisms for 5-HTT control of PPI and perseverative behavior using mouse models
使用小鼠模型研究 5-HTT 控制 PPI 和持续行为的机制
  • 批准号:
    7186087
  • 财政年份:
    2007
  • 资助金额:
    $ 18.05万
  • 项目类别:
Mechanisms for 5-HTT control of PPI and perseverative behavior using mouse models
使用小鼠模型研究 5-HTT 控制 PPI 和持续行为的机制
  • 批准号:
    7571592
  • 财政年份:
    2007
  • 资助金额:
    $ 18.05万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了